Vericel Corporation (VCEL)
VCEL moved a median of -0.19% 30 minutes after news, and -0.13% by the close. How VCEL actually reacts to news — the realized, point-in-time move the market made, measured across 406 labeled events over the last three years with zero look-ahead.
VCEL’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.03% | 52% | 405 |
| 30-min | -0.19% | 40% | 406 |
| 60-min | -0.22% | 43% | 406 |
| to close | -0.13% | 48% | 404 |
| Middle 50% of VCEL reactions | -0.88% to +0.58% |
|---|---|
| Median reaction (30-min) | -0.19% |
| Measured reactions | 406 |
Half of all Vericel Corporation news events land between -0.88% and +0.58% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How VCEL reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 21 | +0.52% | 81% | -0.26% |
| Analyst downgrades | 18 | +0.37% | 56% | +0.21% |
| Coverage initiations | 10 | -0.13% | 50% | +1.22% |
| Rating reiterations | 54 | +0.22% | 59% | +1.08% |
| Price-target raises | 13 | +0.23% | 62% | +1.31% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 1 further class was observed with fewer than 10 measured events and is not published. See how VCEL ranks against every other measured name →
That’s how VCEL usually reacts — get an email when it moves on news →Email me when VCEL moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to VCEL's baseline. Nothing else.
Recent VCEL events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026 | Press release | GlobeNewswire | -0.73% | -1.54% | |
| Form 10-Q Vericel Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.30% | -2.64% | |
| Form 8-K Vericel Corp For: Jul 30 | SEC filing · Form 8-K | SEC EDGAR | -1.30% | -2.64% | |
| Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program | Press release | GlobeNewswire | -1.30% | -2.64% | |
| Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026 | Press release | GlobeNewswire | +0.11% | +1.25% | |
| Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026 | Press release | GlobeNewswire | +0.84% | +0.98% | |
| Form 8-K Vericel Corp For: May 18 | SEC filing · Form 8-K | SEC EDGAR | -0.88% | -1.68% | |
| Form 10-Q Vericel Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -8.39% | -13.26% | |
| Form 8-K Vericel Corp For: May 07 | SEC filing · Form 8-K | SEC EDGAR | -8.39% | -13.26% | |
| Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance | Press release | GlobeNewswire | -8.39% | -13.26% | |
| Form 8-K Vericel Corp For: Apr 29 | SEC filing · Form 8-K | SEC EDGAR | +1.94% | +2.82% | |
| Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026 | Press release | GlobeNewswire | +0.75% | -0.17% | |
| Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines | Press release | PR Newswire | -0.06% | -0.50% | |
| Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid | Press release | GlobeNewswire | +0.85% | -0.03% | |
| Form ARS Vericel Corp For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.93% | +1.36% | |
| Form DEF 14A Vericel Corp For: Apr 29 | SEC filing · Form DEF | SEC EDGAR | -0.93% | +1.36% | |
| Form DEFA14A Vericel Corp | SEC filing · Form DEFA14A | SEC EDGAR | -0.93% | +1.36% | |
| Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility | Press release | GlobeNewswire | -2.00% | -0.34% | |
| Vericel to Present at Multiple Upcoming Investor Conferences | Press release | GlobeNewswire | +0.00% | +0.20% | |
| Form 10-K Vericel Corp For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.03% | +0.99% | |
| Form 8-K Vericel Corp For: Feb 26 | SEC filing · Form 8-K | SEC EDGAR | -0.03% | +0.99% | |
| Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results | Press release | GlobeNewswire | -0.03% | +0.99% | |
| Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026 | Press release | GlobeNewswire | +0.42% | -2.08% | |
| Form 8-K Vericel Corp For: Jan 13 | SEC filing · Form 8-K | SEC EDGAR | -0.16% | -1.33% | |
| Vericel Announces Preliminary 2025 Financial Results and Business Updates | Press release | GlobeNewswire | -0.16% | -1.33% | |
| Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 | Press release | GlobeNewswire | +0.24% | +6.38% | |
| Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025 | Press release | GlobeNewswire | +0.92% | +1.53% | |
| Form 10-Q Vericel Corp For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.10% | -6.90% | |
| Form 8-K Vericel Corp For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | -3.10% | -6.90% | |
| Vericel Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | -3.10% | -6.90% | |
| Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025 | Press release | GlobeNewswire | +1.96% | -0.69% | |
| Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025 | Press release | GlobeNewswire | -0.14% | -0.50% | |
| Form 10-Q Vericel Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.92% | -5.52% | |
| Form 8-K Vericel Corp For: Jul 31 | SEC filing · Form 8-K | SEC EDGAR | -0.92% | -5.52% | |
| Vericel Reports Second Quarter 2025 Financial Results | Press release | GlobeNewswire | -0.92% | -5.52% | |
| Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025 | Press release | GlobeNewswire | +0.29% | -2.76% | |
| Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025 | Press release | GlobeNewswire | +1.09% | +4.05% | |
| Dimension Bio Appoints Biotech Veteran Heidi Hagen to Board of Directors | Press release | PR Web | +0.22% | +0.62% | |
| Form 10-Q Vericel Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -2.57% | +4.03% | |
| Form 8-K Vericel Corp For: May 08 | SEC filing · Form 8-K | SEC EDGAR | -2.57% | +4.03% | |
| Form S-8 Vericel Corp | SEC filing · Form S-8 | SEC EDGAR | +0.68% | -0.12% | |
| Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance | Press release | GlobeNewswire | -2.57% | +4.03% | |
| Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025 | Press release | GlobeNewswire | -0.90% | +4.28% | |
| Form 8-K Vericel Corp For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | -0.47% | +1.74% | |
| Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025 | Press release | GlobeNewswire | -0.31% | +2.24% | |
| Form 8-K Vericel Corp For: Apr 14 | SEC filing · Form 8-K | SEC EDGAR | -5.46% | -2.55% | |
| Form ARS Vericel Corp For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.73% | +0.36% | |
| Form DEF 14A Vericel Corp For: Apr 30 | SEC filing · Form DEF | SEC EDGAR | -0.73% | +0.36% | |
| Form DEFA14A Vericel Corp | SEC filing · Form DEFA14A | SEC EDGAR | -0.73% | +0.36% | |
| Vericel to Present at Multiple Upcoming Investor Conferences | Press release | GlobeNewswire | +1.19% | +4.62% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the VCEL section they belong to.
Where else VCEL is measured.
VCEL earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ALLIQUA BIOMEDICAL (ALQA) | 407 | -0.11% | 43% |
| NeoGenomics, Inc. (NEO) | 406 | -0.22% | 44% |
| SPRING BANK PHARMACEUTICALS (SBPH) | 404 | 0.00% | 37% |
| AKCEA THERAPEUTICS (AKCA) | 401 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Vericel Corporation's median reaction calculated?
Every labeled VCEL news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 406 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 40% of VCEL's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does VCEL's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.